Form D · Other
Bold Therapeutics Inc.
Vancouver, A1 · CIK 0001845276
Offering snapshot reported Feb 9, 2021 · SEC filing
- Reported sold
- $5.48M Offering amount: $10M
- Investors reported
- 48 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 12, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 9, 2021 | Initial | $5,477,404 | No comparison | 48 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-388924
Source: Form D, filed Feb 9, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Edward Russell Mc Allister | Director, Executive |
| James Pankovich | Director, Executive |
| Hooshmand Sheshbaradaran | Director |
| Simon Sutcliffe | Director |
| Glenn Walthall | Director |
Issuer details
Industry: Other (See others in industry)
Address:
850 West Hastings Street Suite 515
Vancouver, A1, V6C1E1
Vancouver, A1, V6C1E1